Picton Mahoney Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.3M | Buy |
76,814
+76,808
| +1,280,133% | +$14.3M | 0.15% | 120 |
|
2025
Q1 | $1K | Hold |
6
| – | – | ﹤0.01% | 664 |
|
2024
Q4 | $1K | Hold |
6
| – | – | ﹤0.01% | 561 |
|
2024
Q3 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 560 |
|
2023
Q2 | – | Sell |
-53,717
| Closed | -$8.56M | – | 412 |
|
2023
Q1 | $8.56M | Sell |
53,717
-10,799
| -17% | -$1.72M | 0.38% | 80 |
|
2022
Q4 | $10.4M | Sell |
64,516
-3,189
| -5% | -$515K | 0.49% | 46 |
|
2022
Q3 | $9.09M | Buy |
67,705
+675
| +1% | +$90.6K | 0.33% | 51 |
|
2022
Q2 | $10.3M | Buy |
67,030
+46,865
| +232% | +$7.18M | 0.39% | 44 |
|
2022
Q1 | $3.27M | Buy |
+20,165
| New | +$3.27M | 0.12% | 221 |
|
2018
Q2 | – | Sell |
-209,600
| Closed | -$19.8M | – | 175 |
|
2018
Q1 | $19.8M | Buy |
209,600
+78,300
| +60% | +$7.41M | 1.43% | 18 |
|
2017
Q4 | $12.7M | Buy |
+131,300
| New | +$12.7M | 0.91% | 44 |
|
2015
Q1 | – | Sell |
-274,900
| Closed | -$18M | – | 270 |
|
2014
Q4 | $18M | Sell |
274,900
-14,200
| -5% | -$929K | 0.86% | 37 |
|
2014
Q3 | $16.7K | Buy |
289,100
+49,300
| +21% | +$2.85K | 0.9% | 40 |
|
2014
Q2 | $13.5K | Sell |
239,800
-271,200
| -53% | -$15.3K | 0.79% | 44 |
|
2014
Q1 | $26.3M | Buy |
511,000
+180,200
| +54% | +$9.26M | 1.52% | 11 |
|
2013
Q4 | $17.5M | Sell |
330,800
-15,600
| -5% | -$824K | 1.02% | 23 |
|
2013
Q3 | $15.5M | Sell |
346,400
-90,900
| -21% | -$4.07M | 1.02% | 26 |
|
2013
Q2 | $18.1M | Buy |
+437,300
| New | +$18.1M | 1.34% | 15 |
|